Decrease in hospitalization for treatment of childhood asthma with increased use of antiinflammatory treatment, despite an increase in prevalence of asthma
View abstract on PubMed
Summary
This summary is machine-generated.Childhood asthma hospitalizations decreased significantly due to inhaled steroid treatment. This anti-inflammatory approach proved highly effective and cost-efficient for pediatric asthma management.
Area Of Science
- Pediatric Pulmonology
- Public Health
- Pharmacotherapy
Background
- Asthma prevalence in Swedish children doubled over 15 years.
- Inhaled steroid anti-inflammatory treatment increased concurrently since 1985.
Purpose Of The Study
- To evaluate the impact of increased inhaled steroid use on pediatric asthma hospitalizations.
- To analyze trends in hospital days and admissions for childhood asthma.
Main Methods
- Population-based study in Göteborg, Sweden (0.5 million inhabitants).
- Data collected on hospital days, admissions, and individual patients for acute asthma (1985-1993).
- Centralized inpatient care at a single children's hospital; consistent hospitalization policies.
Main Results
- Significant decrease in hospital days (to <1/3) and admissions (by 45%) for children aged 2-18 years.
- Most pronounced reduction in older children (>5 years): hospital days reduced to 1/5, admissions halved.
- Decreasing trend in hospital days observed in 2-5 year olds; no significant trend in individual patient admissions.
Conclusions
- Inhaled steroids are the primary driver for reduced pediatric asthma hospitalizations (ages 2-18).
- Parent/patient education may be a contributing factor.
- Anti-inflammatory treatment with inhaled steroids is a cost-effective strategy for pediatric asthma.